WASHINGTON – U. S. fitness officialsBut it’s not the first time They have presented two new studies to control anticoagulants and prevent strokes, attacks on the center, blood clots and other headaches in patients with COVID-19.
Doctors are locating blood clots in the bodies of many other people who have died of COVID-19, as well as symptoms of damage to the kidneys, lungs, blood vessels, center and other organs.
Gary Gibbons, director of the National Heart, Lung and Blood Institute, said hospitals were giving critical patients anticoagulant medications to review and save this, but “frankly, we didn’t know how productive it was to treat it” in terms of medication. dose to use and at what level of the disease.
The National Institutes of Health will coordinate a study in hospitalized patients by comparing low and normal doses of anticoagulant heparin. The study will involve more than a hundred sites around the world participating in a study effort with governments, pharmaceutical companies, universities and others to boost coronavirus therapies.
One time examine in patients with COVID-19 who are not enough to require hospitalization w check other methods opposite placebo ps: aspirin for infants or low or normal doses of anticoagulant apixaban, sold as Eliquis in the United States. blood clots or hospitalization.
A third test that begins later will check for blood thinners for others who have recovered and no longer test positive for coronavirus. They have been shown to remain at high risk for blood clots.